{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:51:40Z","timestamp":1794592300016,"version":"4.9.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>It is hypothesized that the extent and severity of fibrosis and cellularity found on lung biopsy determine the prognosis and response to therapy in idiopathic pulmonary fibrosis (IPF). The objective of this study was to determine which histopathologic features predict survival in IPF. We prospectively studied 87 patients with usual interstitial pneumonia (UIP) confirmed by surgical lung biopsy. Four pathologists independently graded the extent and severity of specific histopathologic features. We used Cox proportional-hazards models to assess the effect of histopathologic patterns on patients' survival. The effects of age, sex, and smoking were also included in the analysis. Sixty-three patients died during the 17-yr study period. Survival was longer in subjects with lesser degrees of granulation\/connective tissue deposition (fibroblastic foci). The degree of alveolar space cellularity, alveolar wall fibrosis, and cellularity did not affect survival. A history of cigarette smoking, the level of dyspnea, and the degree of lung stiffness at presentation were also shown to be independent factors predicting survival. The extent of fibroblastic foci present on lung biopsy predicts survival in IPF. These findings support the hypothesis that the critical pathway to end-stage fibrosis is not \u201calveolitis\u201d but rather the ongoing epithelial damage and repair process associated with persistent fibroblastic proliferation. Controlling these processes, rather than stopping inflammation, appears most important in preventing progressive disease and the fatal outcome common in IPF.<\/jats:p>","DOI":"10.1164\/ajrccm.164.6.2001056","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:50:15Z","timestamp":1365087015000},"page":"1025-1032","source":"Crossref","is-referenced-by-count":510,"title":["Idiopathic Pulmonary Fibrosis"],"prefix":"10.1093","volume":"164","author":[{"suffix":"JR.","given":"TALMADGE E.","family":"KING","sequence":"first","affiliation":[{"name":"Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco, San Francisco, California; Department of Medicine, National Jewish Medical and Research Center, and the Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado; Departments of Pathology, Mayo Clinic, Scottsdale, Arizona; University of Arkansas, Little Rock, Arkansas; University of Michigan, Ann Arbor, Michigan; University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARVIN I.","family":"SCHWARZ","sequence":"additional","affiliation":[{"name":"Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco, San Francisco, California; Department of Medicine, National Jewish Medical and Research Center, and the Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado; Departments of Pathology, Mayo Clinic, Scottsdale, Arizona; University of Arkansas, Little Rock, Arkansas; University of Michigan, Ann Arbor, Michigan; University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KEVIN","family":"BROWN","sequence":"additional","affiliation":[{"name":"Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco, San Francisco, California; Department of Medicine, National Jewish Medical and Research Center, and the Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado; Departments of Pathology, Mayo Clinic, Scottsdale, Arizona; University of Arkansas, Little Rock, Arkansas; University of Michigan, Ann Arbor, Michigan; University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JANET A.","family":"TOOZE","sequence":"additional","affiliation":[{"name":"Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco, San Francisco, California; Department of Medicine, National Jewish Medical and Research Center, and the Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado; Departments of Pathology, Mayo Clinic, Scottsdale, Arizona; University of Arkansas, Little Rock, Arkansas; University of Michigan, Ann Arbor, Michigan; University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"THOMAS V.","family":"COLBY","sequence":"additional","affiliation":[{"name":"Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco, San Francisco, California; Department of Medicine, National Jewish Medical and Research Center, and the Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado; Departments of Pathology, Mayo Clinic, Scottsdale, Arizona; University of Arkansas, Little Rock, Arkansas; University of Michigan, Ann Arbor, Michigan; University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"JR.","given":"JAMES A.","family":"WALDRON","sequence":"additional","affiliation":[{"name":"Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco, San Francisco, California; Department of Medicine, National Jewish Medical and Research Center, and the Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado; Departments of Pathology, Mayo Clinic, Scottsdale, Arizona; University of Arkansas, Little Rock, Arkansas; University of Michigan, Ann Arbor, Michigan; University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDREW","family":"FLINT","sequence":"additional","affiliation":[{"name":"Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco, San Francisco, California; Department of Medicine, National Jewish Medical and Research Center, and the Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado; Departments of Pathology, Mayo Clinic, Scottsdale, Arizona; University of Arkansas, Little Rock, Arkansas; University of Michigan, Ann Arbor, Michigan; University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WILLIAM","family":"THURLBECK","sequence":"additional","affiliation":[{"name":"Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco, San Francisco, California; Department of Medicine, National Jewish Medical and Research Center, and the Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado; Departments of Pathology, Mayo Clinic, Scottsdale, Arizona; University of Arkansas, Little Rock, Arkansas; University of Michigan, Ann Arbor, Michigan; University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"REUBEN M.","family":"CHERNIACK","sequence":"additional","affiliation":[{"name":"Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco, San Francisco, California; Department of Medicine, National Jewish Medical and Research Center, and the Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado; Departments of Pathology, Mayo Clinic, Scottsdale, Arizona; University of Arkansas, Little Rock, Arkansas; University of Michigan, Ann Arbor, Michigan; University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,9,15]]},"reference":[{"key":"2026032708063440500_B1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/ajrccm.157.1.9704130","article-title":"Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis.","volume":"157","author":"Bjoraker","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708063440500_B2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1164\/ajrccm.149.2.8306043","article-title":"Determinants of progression in idiopathic pulmonary fibrosis.","volume":"149","author":"Schwartz","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708063440500_B3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/thx.35.3.171","article-title":"Cryptogenic fibrosing alveolitis: clinical features and their influence on survival.","volume":"35","author":"Turner-Warwick","year":"1980","journal-title":"Thorax"},{"key":"2026032708063440500_B4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1164\/ajrccm.149.2.8306044","article-title":"Determinants of survival in idiopathic pulmonary fibrosis.","volume":"149","author":"Schwartz","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708063440500_B5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1164\/ajrccm.157.4.9703022","article-title":"J, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ. Idiopathic pulmonary fibrosis: predicting response to therapy and survival.","volume":"157","author":"Gay","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708063440500_B6","first-page":"1","article-title":"Cryptogenic fibrosing alveolitis relationships of pulmonary physiology and bronchoalveolar lavage to treatment and prognosis.","volume":"124","author":"Rudd","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"2026032708063440500_B7","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1164\/ajrccm.157.4.9707039","article-title":"Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification.","volume":"157","author":"Katzenstein","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708063440500_B8"},{"key":"2026032708063440500_B9"},{"key":"2026032708063440500_B10"},{"key":"2026032708063440500_B11"},{"key":"2026032708063440500_B12"},{"key":"2026032708063440500_B13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1164\/arrd.1986.133.1.97","article-title":"A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis.","volume":"133","author":"Watters","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"2026032708063440500_B14"},{"key":"2026032708063440500_B15"},{"key":"2026032708063440500_B16"},{"key":"2026032708063440500_B17"},{"key":"2026032708063440500_B18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1164\/ajrccm.160.3.9903021","article-title":"A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis.","volume":"160","author":"Daniil","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708063440500_B19","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1183\/09031936.98.12051010","article-title":"Idiopathic nonspecific interstitial pneumonia\/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP.","volume":"12","author":"Nagai","year":"1998","journal-title":"Eur Respir J"},{"key":"2026032708063440500_B20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM197804132981501","article-title":"Natural history and treated course of usual and desquamative interstitial pneumonia.","volume":"298","author":"Carrington","year":"1978","journal-title":"N Engl J Med"},{"key":"2026032708063440500_B21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJM197802162980701","article-title":"Circulating immune complexes in the idiopathic interstitial pneumonias.","volume":"298","author":"Dreisin","year":"1978","journal-title":"N Engl J Med"},{"key":"2026032708063440500_B22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0002-9343(78)90855-0","article-title":"Diffuse interstitial pneumonitis: clinicopathologic correlations in 20 patients treated with prednizone\/azathioprine.","volume":"65","author":"Winterbauer","year":"1978","journal-title":"Am J Med"},{"key":"2026032708063440500_B23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0007-0971(81)80008-3","article-title":"Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features.","volume":"75","author":"Wright","year":"1981","journal-title":"Br J Dis Chest"},{"key":"2026032708063440500_B24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/thx.38.5.349","article-title":"Prognosis of cryptogenic fibrosing alveolitis.","volume":"38","author":"Tukiainen","year":"1983","journal-title":"Thorax"},{"key":"2026032708063440500_B25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1378\/chest.114.2.507","article-title":"Colchicine, d-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial.","volume":"114","author":"Selman","year":"1998","journal-title":"Chest"},{"key":"2026032708063440500_B26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1164\/ajrccm\/144.2.291","article-title":"Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective, double-blind randomized, placebo-controlled clinical trial.","volume":"144","author":"Raghu","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"2026032708063440500_B27"},{"key":"2026032708063440500_B28"},{"key":"2026032708063440500_B29"},{"key":"2026032708063440500_B30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/thx.52.1.38","article-title":"the Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management.","volume":"52","author":"Johnston","year":"1997","journal-title":"Thorax"},{"key":"2026032708063440500_B31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1164\/ajrccm.150.3.8087336","article-title":"Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure.","volume":"150","author":"Iwai","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708063440500_B32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0140-6736(96)90465-1","article-title":"Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis.","volume":"347","author":"Hubbard","year":"1996","journal-title":"Lancet"},{"key":"2026032708063440500_B33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/ajrccm.155.1.9001319","article-title":"the Collaborating Centers. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.","volume":"155","author":"Baumgartner","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708063440500_B34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1378\/chest.98.1.71","article-title":"Interactions between cigarette smoking and the natural history of idiopathic pulmonary fibrosis.","volume":"98","author":"de Cremoux","year":"1990","journal-title":"Chest"},{"key":"2026032708063440500_B35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1378\/chest.113.2.396","article-title":"Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study.","volume":"113","author":"Hubbard","year":"1998","journal-title":"Chest"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/164\/6\/1025\/67583769\/ajrccm_164_6_1025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/164\/6\/1025\/67583769\/ajrccm_164_6_1025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:06:41Z","timestamp":1774613201000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/164\/6\/1025\/8544604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2001,9,15]]},"published-print":{"date-parts":[[2001,9,15]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.164.6.2001056","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2001,9]]},"published":{"date-parts":[[2001,9]]}}}